Beyond the Standard of Care

danielfavaro2828
  • 0.0 (0)
  • Medicine
  • Daily

Medicine evolves because researchers continue asking difficult questions. This podcast explores scientific literature on cancer and other diseases, focusing on emerging biological mechanisms, repurposed medications, metabolism, immunology, infectious disease, nutrition, and experimental therapeutic approaches. Episodes examine peer-reviewed evidence, discuss competing hypotheses, and highlight both the promise and limitations of current research. Intended for physicians, researchers, healthcare professionals, and evidence-minded listeners.

Episodes

  1. Jul 16

    Medical Controversies #005 | Giuseppe Calligaris: The Forgotten Physician Who Mapped Emotions onto the Skin

    Who was Giuseppe Calligaris, and why did some consider his work one of the most extraordinary lost chapters in twentieth-century medicine? In this episode of Beyond the Standard of Care, we explore the life, discoveries, and controversies surrounding the Italian physician whose research proposed unexpected connections between the skin, emotions, internal organs, and states of consciousness. We discuss Calligaris' early medical career, his pioneering academic work, the impact of the World Wars on the preservation and dissemination of his research, and the theories that later became known as dermorreflexology and dermosomatics. The conversation examines concepts such as skin lines, tactile stimulation, emotional states, alpha brain waves, and the relationship between touch and healing, while also distinguishing historical theories from modern evidence-based medicine. Were Calligaris' observations misunderstood discoveries ahead of their time, or do they belong to the long history of alternative medical theories that challenged conventional science? Join us for an exploration of one of medicine's most unusual and fascinating intellectual journeys. This episode is intended for educational and historical discussion only and should not be interpreted as medical advice or as an endorsement of any therapeutic claims discussed.

  2. Jul 13

    Clinical Education #002 | Circadian Rhythms, Metabolism, and the Rhythm of Longevity

    In this episode of Clinical Education, we explore one of the most fundamental yet frequently overlooked determinants of human health: the circadian rhythm. Drawing from the chapter "Circadian Rhythm" from the upcoming book The Rhythm of Longevity, we examine how the body's internal clock coordinates metabolism, hormone production, energy regulation, sleep, and recovery. The discussion explores the role of the suprachiasmatic nucleus (SCN) as the body's master clock, how light exposure regulates cortisol and melatonin secretion, the relationship between sleep quality and metabolic health, the principles of chrononutrition and meal timing, the interaction between circadian biology and insulin sensitivity, and how different nutritional approaches—including carnivore, low-carbohydrate, and plant-based dietary patterns—may benefit from timing strategies aligned with human biological rhythms. The episode also examines the growing field of chronobiology and its implications for obesity, metabolic dysfunction, energy regulation, and healthy aging. As modern lifestyles increasingly disconnect us from natural environmental cues, understanding the timing of sleep, light exposure, physical activity, and food intake may prove to be as important as the specific foods we eat. Whether you are a physician, nutritionist, healthcare professional, researcher, or simply interested in optimizing your health and longevity, this episode offers a practical and scientifically grounded introduction to the emerging science of biological timing.

  3. Jul 10

    History of Medicine #001 | Propolis, Petroleum, and Ancient Medicine: What Did the Healers of the Past Know?

    Por que civilizações antigas tão diferentes entre si utilizavam substâncias como própolis, resinas e até derivados naturais do petróleo para tratar doenças e ferimentos? Neste episódio, viajamos pela fascinante história dos remédios tradicionais e das práticas médicas esquecidas pelo tempo. Exploramos como antigas culturas descobriram propriedades terapêuticas em substâncias encontradas na natureza, como essas ideias atravessaram séculos e de que forma a medicina moderna passou a enxergar esses conhecimentos. Será que algumas dessas observações ancestrais continham elementos que a ciência só viria a compreender muito mais tarde? E por que certos tratamentos sobreviveram por milhares de anos enquanto outros desapareceram completamente? Ao longo desta jornada, distinguimos cuidadosamente entre tradição, relatos históricos e evidências científicas contemporâneas, em uma conversa que mistura história, curiosidades e a evolução do pensamento médico ao longo dos séculos. Se você gosta de mistérios da história da medicina, descobertas esquecidas e debates científicos fascinantes, este episódio foi feito para você.

  4. Jul 8

    Revisão da Literatura #001 | Ivermectina e Câncer: O Que as Evidências Científicas Mostram?

    Neste primeiro episódio da série Revisão da Literatura, exploramos um dos temas mais discutidos da oncologia translacional e da pesquisa em reposicionamento de fármacos: o potencial papel da ivermectina no tratamento do câncer. A partir de estudos experimentais, revisões científicas e pesquisas recentes, analisamos os mecanismos biológicos que levaram pesquisadores a investigar a ivermectina como um possível agente anticâncer, incluindo seus efeitos sobre apoptose, autofagia, angiogênese, metabolismo tumoral, células-tronco cancerígenas e vias de sinalização celular. Mas até que ponto essas evidências permanecem restritas a estudos laboratoriais e modelos animais? O que já foi investigado em seres humanos? E quais são as diferenças entre resultados pré-clínicos promissores e terapias efetivamente incorporadas à prática médica? Ao longo deste episódio, discutimos também o crescente interesse pelo reposicionamento de medicamentos na oncologia moderna e os desafios envolvidos na transição entre descobertas laboratoriais e aplicações clínicas. Esta conversa é baseada em literatura científica e publicações revisadas por pares, com o objetivo de distinguir claramente entre hipóteses biológicas, evidências pré-clínicas, estudos clínicos e consenso científico atual. Se você é médico, pesquisador, profissional da saúde, estudante ou simplesmente possui interesse em biologia do câncer e inovação terapêutica, este episódio oferece uma análise detalhada de um dos temas mais debatidos da pesquisa oncológica contemporânea.

  5. Jul 6

    Educação Clínica #001 | O que é a SPES? Formação Avançada em Medicina Integrativa e Saúde Metabólica

    Neste primeiro episódio da série Educação Clínica, apresentamos a SPES e sua proposta de formação para profissionais da saúde que desejam aprofundar seus conhecimentos em medicina integrativa, saúde metabólica e manejo de doenças crônicas. Ao longo da conversa, exploramos a filosofia educacional da instituição, seus programas de pós-graduação e educação continuada, o modelo de ensino com aulas ao vivo e a integração entre diferentes áreas do conhecimento clínico. Também discutimos temas como cronobiologia, saúde intestinal, metabolismo, medicina personalizada e a importância de uma abordagem multidisciplinar no atendimento ao paciente. O episódio destaca como a formação especializada pode contribuir para o desenvolvimento do raciocínio clínico, da tomada de decisões baseadas em evidências e da aplicação prática de novos conhecimentos na rotina profissional. Mais do que apresentar uma instituição de ensino, esta conversa convida o profissional da saúde a refletir sobre a importância da atualização contínua diante dos desafios crescentes das doenças crônicas e metabólicas. Se você é médico, nutricionista, farmacêutico, dentista, fisioterapeuta, enfermeiro ou outro profissional da saúde interessado em ampliar sua formação clínica, este episódio oferece uma visão geral da proposta educacional da SPES e de como seus programas buscam preparar profissionais para uma prática cada vez mais integrada e centrada no paciente.

  6. Jul 6

    Medical Controversies #004 | Dr. Alfons Weber, Tamara Lebedewa, and the Challenge to Conventional Oncology

    This short documentary introduces the work of Dr. Alfons Weber, Tamara Lebedewa, and other researchers whose ideas challenged prevailing concepts in cancer research. Drawing from the source collection—including Falência Cancer—the video summarizes their perspectives on the origins of cancer, their criticisms of conventional oncology, and their proposed alternatives to standard diagnostic and therapeutic approaches. Rather than attempting to resolve these debates, the video presents the historical arguments made by these researchers and highlights the broader questions they raised about scientific innovation, institutional medicine, and the evaluation of unconventional medical hypotheses. This short feature serves as an introduction to a larger discussion explored throughout the Medical Controversies series, where these ideas are examined in greater depth, compared with established oncology, and considered in light of current scientific evidence.

  7. Jul 6

    Medical Controversies #003 | How the Microparasite Theory Proposes Cancer Develops

    This short visual presentation illustrates the proposed biological mechanism described by proponents of the microparasite theory of cancer. Using simplified diagrams and animation, it summarizes how the theory suggests chronic parasitic infection, immune dysfunction, and progressive cellular changes could contribute to the development of cancer. The video is intended as a visual explanation of the hypothesis itself rather than a comprehensive review of the available scientific evidence. It represents the concepts described in the source material and should be understood within the broader context of ongoing scientific discussion about cancer biology. For a more detailed examination of the historical background, supporting arguments, criticisms, and comparison with established oncology, listen to the companion episode of Medical Controversies, where the theory is analyzed in greater depth and placed within the context of modern cancer research.

  8. Jul 6

    Medical Controversies #002 | Is Cancer a Parasitic Disease? Examining the Trichomonas Theory

    This episode examines one of the most controversial hypotheses in alternative oncology: the proposal that chronic infection with the protozoan Trichomonas is the underlying cause of cancer and leukemia. Drawing from the source material, we explore the biological model proposed by its author, including the argument that many structures identified as cancer cells or abnormal lymphocytes represent different developmental stages of parasitic organisms. The discussion also reviews the proposed roles of immune dysfunction, the thymus gland, immunomodulatory therapies such as Timalin and Roncoleukin, bio-resonance diagnostics, and peptide-based treatment strategies. The episode contrasts these claims with the principles of modern oncology and examines why such theories remain outside mainstream medical practice. We discuss the standards of scientific evidence used to evaluate unconventional medical hypotheses, the challenges of validating novel diagnostic methods, and the ethical responsibilities involved when proposing alternatives to established cancer treatments. Throughout the discussion, we distinguish between the claims presented by the source, historical observations, published research, established scientific consensus, and hypotheses that remain controversial or unverified. This episode is intended as an exploration of a controversial medical theory and the scientific questions surrounding it. It is not a recommendation for diagnosis or treatment but an opportunity to examine how medicine evaluates extraordinary claims through evidence, reproducibility, and clinical research.

  9. Jul 6

    Controvérsias Médicas #001 | A Teoria dos Microparasitas no Câncer: História, Evidências e Debate

    No primeiro episódio da série Controvérsias Médicas, exploramos uma das hipóteses mais controversas da história da pesquisa sobre o câncer: a teoria dos microparasitas. Quem foi o Dr. Weber e o que exatamente ele propôs? Quem foram Tamara Lebedewa, Melnikova, Wollenberg e outros pesquisadores que defenderam abordagens diferentes das aceitas pela oncologia convencional? Quais evidências apresentaram, quais métodos diagnósticos utilizaram e por que suas ideias geraram tanta controvérsia? Com base nas fontes analisadas, este episódio reconstrói o contexto histórico entre 1968 e 2002, período em que a pesquisa em oncologia evoluiu rapidamente enquanto teorias alternativas buscavam espaço no debate científico. Também discutimos como os padrões de diagnóstico, a medicina baseada em evidências e as instituições científicas responderam a essas propostas. Além dos aspectos científicos, analisamos os desafios éticos envolvidos quando hipóteses não convencionais confrontam o consenso médico: como distinguir inovação científica de especulação? Como equilibrar abertura para novas ideias com a responsabilidade de proteger pacientes por meio de pesquisas rigorosas? Este episódio tem caráter histórico e científico. O objetivo é compreender como essas teorias surgiram, como foram avaliadas pela comunidade médica e quais questões permanecem em aberto, distinguindo claramente entre fatos históricos, evidências publicadas, consenso científico e hipóteses que continuam controversas ou não comprovadas. Se você é médico, pesquisador, profissional da saúde, estudante ou simplesmente tem interesse pela história da medicina e pelo desenvolvimento da pesquisa em câncer, este episódio oferece uma análise crítica e equilibrada de um dos debates mais intrigantes da oncologia moderna.

  10. Jul 5

    Medical Controversies #001 | The Microparasite Theory of Cancer: History, Evidence, and Debate

    In the inaugural episode of the Medical Controversies series, we examine one of the most debated and unconventional hypotheses in cancer research: the microparasite theory of cancer. Who was Dr. Weber, and what did he propose? Who were Tamara Lebedewa, Melnikova, Wollenberg, and the other physicians and independent researchers whose work challenged prevailing views of cancer and chronic disease? What evidence did they present, how were their ideas received by the medical establishment, and how do these claims compare with current scientific understanding? Drawing from historical documents, published sources, and medical literature, this episode explores the origins of these theories, the diagnostic methods they employed, and how they differed from standard clinical approaches to gynecological infections and cancer pathology. We also examine the broader historical context of oncology from the late 1960s through the early 2000s, including the evolution of cancer diagnostics, institutional research practices, and changing public confidence in medical institutions. Beyond the scientific questions, we discuss the ethical challenges that arise whenever unconventional ideas confront established medical consensus. How should medicine evaluate extraordinary claims? What responsibilities do research institutions have to investigate novel hypotheses while protecting patients from ineffective or harmful interventions? Where is the balance between scientific skepticism and openness to innovation? This episode is intended as a historical and scientific analysis—not an endorsement of any particular theory or treatment. Throughout the discussion, we distinguish between documented historical events, established medical evidence, and hypotheses that remain controversial or unverified. Whether you are a physician, researcher, healthcare professional, student, or simply interested in the history and philosophy of medicine, this episode offers a thoughtful exploration of one of oncology's most enduring controversies.

  11. Jul 4

    Research Review #001: Drug Repurposing in Oncology: Exploring the Evidence Behind Ivermectin

    Ivermectin has generated considerable interest as a potential anticancer agent, with laboratory studies suggesting effects on apoptosis, tumor metabolism, autophagy, angiogenesis, cancer stem cells, and multiple cellular signaling pathways. But how much of this evidence comes from cell cultures and animal models, and what has actually been demonstrated in human clinical research? In this episode of Beyond the Standard Care, we examine peer-reviewed publications exploring ivermectin as a possible anticancer therapy. We discuss the proposed biological mechanisms, the strengths and limitations of the current evidence, why drug repurposing has become an important field in oncology, and the critical distinction between preclinical findings and clinical outcomes. This conversation is based on published scientific literature and review articles rather than promotional materials or anecdotal reports. The objective is to understand what researchers are investigating, where the evidence is strongest, where uncertainty remains, and which questions future clinical trials will need to answer. Whether you are a physician, researcher, healthcare professional, student, or simply interested in cancer biology, this episode provides a comprehensive overview of one of the most discussed repurposed drugs in oncology research.

  • 11 Episodes

About

Medicine evolves because researchers continue asking difficult questions. This podcast explores scientific literature on cancer and other diseases, focusing on emerging biological mechanisms, repurposed medications, metabolism, immunology, infectious disease, nutrition, and experimental therapeutic approaches. Episodes examine peer-reviewed evidence, discuss competing hypotheses, and highlight both the promise and limitations of current research. Intended for physicians, researchers, healthcare professionals, and evidence-minded listeners.

Information